BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24071582)

  • 41. HPV 16E7 and 48E7 proteins use different mechanisms to target p130 to overcome cell cycle block.
    Nor Rashid N; Yong ZL; Yusof R; Watson RJ
    Virol J; 2016 Jan; 13():2. PubMed ID: 26728921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb.
    Iness AN; Felthousen J; Ananthapadmanabhan V; Sesay F; Saini S; Guiley KZ; Rubin SM; Dozmorov M; Litovchick L
    Oncogene; 2019 Feb; 38(7):1080-1092. PubMed ID: 30206359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.
    Huang SM; McCance DJ
    J Virol; 2002 Sep; 76(17):8710-21. PubMed ID: 12163591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly.
    Litovchick L; Florens LA; Swanson SK; Washburn MP; DeCaprio JA
    Genes Dev; 2011 Apr; 25(8):801-13. PubMed ID: 21498570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
    Innocente SA; Lee JM
    FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.
    Ruesch MN; Laimins LA
    J Virol; 1997 Jul; 71(7):5570-8. PubMed ID: 9188631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
    Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The human papillomavirus type 16 E7 oncoprotein targets Myc-interacting zinc-finger protein-1.
    Morandell D; Kaiser A; Herold S; Rostek U; Lechner S; Mitterberger MC; Jansen-Dürr P; Eilers M; Zwerschke W
    Virology; 2012 Jan; 422(2):242-53. PubMed ID: 22099967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A functional interaction of E7 with B-Myb-MuvB complex promotes acute cooperative transcriptional activation of both S- and M-phase genes. (129 c).
    Pang CL; Toh SY; He P; Teissier S; Ben Khalifa Y; Xue Y; Thierry F
    Oncogene; 2014 Jul; 33(31):4039-49. PubMed ID: 24141769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Engineering an improved cell cycle-regulatable herpes simplex virus type 1 amplicon vector with enhanced transgene expression in proliferating cells yet attenuated activities in resting cells.
    Wang GY; Ho IA; Sia KC; Miao L; Hui KM; Lam PY
    Hum Gene Ther; 2007 Mar; 18(3):222-31. PubMed ID: 17355186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
    Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
    J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activation.
    Schade AE; Fischer M; DeCaprio JA
    Nucleic Acids Res; 2019 Dec; 47(21):11197-11208. PubMed ID: 31667499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification and functional analysis of a CDE/CHR element in the POLD1 promoter.
    SONG N; ZHU X; SHI L; AN J; WU Y; SANG J
    Sci China C Life Sci; 2009 Jun; 52(6):551-9. PubMed ID: 19557333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CIP2A facilitates the G1/S cell cycle transition via B-Myb in human papillomavirus 16 oncoprotein E6-expressing cells.
    Tian Y; Chen H; Qiao L; Zhang W; Zheng J; Zhao W; Chen JJ; Zhang W
    J Cell Mol Med; 2018 Sep; 22(9):4150-4160. PubMed ID: 29893470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of promoter elements responsible for transcriptional inhibition of polo-like kinase 1 and topoisomerase IIalpha genes by p21(WAF1/CIP1/SDI1).
    Zhu H; Chang BD; Uchiumi T; Roninson IB
    Cell Cycle; 2002 Jan; 1(1):59-66. PubMed ID: 12429910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells.
    Allison SJ; Jiang M; Milner J
    Aging (Albany NY); 2009 Mar; 1(3):316-27. PubMed ID: 20157519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
    Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
    Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
    Nakajima Y
    Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):172-88. PubMed ID: 9711036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Down-regulation of Polo-like kinase 4 (PLK4) induces G1 arrest via activation of the p38/p53/p21 signaling pathway in bladder cancer.
    Yang Z; Sun H; Ma W; Wu K; Peng G; Ou T; Wu S
    FEBS Open Bio; 2021 Sep; 11(9):2631-2646. PubMed ID: 34342940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.